DOI:
10.1055/s-00044881
Journal of Laboratory Physicians
LinksClose Window
References
Zhang H, Ave H.
Advances of FDA approved Drugs that target PD-1 and PD-L1 for cancer immunotherapy.
Am J Cancer Sci 2019;
7 (01) 18-31
We do not assume any responsibility for the contents of the web pages of other providers.